In recent years, AI has become a buzzword in life sciences and health care as the technology has developed to create applications from drug discovery to diagnostics to therapeutics. Most recently, AI has been used in the...more
On January 17, The Belgian Data Protection Authority (DPA) published Recommendation no 01/2020 providing Guidance on direct marketing. The Recommendation provides a methodology on how to comply with the General Data...more
3/6/2020
/ Belgium ,
Data Controller ,
Data Privacy ,
Data Protection ,
Data Protection Authority ,
Direct Marketing ,
EU ,
General Data Protection Regulation (GDPR) ,
Personal Data ,
Regulatory Requirements ,
Transparency
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars....more
12/7/2018
/ Biotechnology ,
Data Privacy ,
Digital Health ,
Drug Pricing ,
Emerging Markets ,
General Data Protection Regulation (GDPR) ,
Investment ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Prescription Drugs ,
Product Exclusivity ,
Regulatory Standards ,
Sunshine Laws ,
UK Brexit
On 27 December 2016, the Belgian Law of 18 December 2016 concerning various health-related matters (“the Sunshine Act”) was adopted by the Belgian Ministry for Public Health....more
5/8/2018
/ Belgium ,
Data Protection ,
Disclosure Requirements ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Medical Devices ,
Personal Data ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Regulatory Standards ,
Sunshine Act
In the EU, digital health technologies such as medical apps or wearable sensors can fall within the scope of the medical devices directives. ...more